Polyuria resident survival guide: Difference between revisions

Jump to navigation Jump to search
(/* Common causes {{cite journal| author=Wieliczko M, Matuszkiewicz-Rowińska J| title=[Polyuria]. | journal=Wiad Lek | year= 2013 | volume= 66 | issue= 4 | pages= 324-8 | pmid=24490488 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24490488 }} {{cite journal| author=Weiss JP, Everaert K| title=Management of Nocturia and Nocturnal Polyuria. | journal=Urology | year= 2019 | volume= 133S | issue= | pag...)
Line 36: Line 36:
**Drinking alcohol or caffeine
**Drinking alcohol or caffeine


==Approach to Polyuria==
==Management==
 
*'''Diagnostic Approach'''
 


{{Family tree/start}}  
{{Family tree/start}}  
Line 64: Line 67:
{{Family tree |,|^|-|-|-|.| | | }}
{{Family tree |,|^|-|-|-|.| | | }}
{{Family tree | K01 | | K02 | | | | | | | |K01=(Initial urine osmolality: 30 mOsm/kg and >50% increase after desmopressin):<br>'''Complete Central DI'''| K02=(Urine osmolality <300 mOsm/kg or <50% increase):<br>'''Complete Nephrogenic DI'''}}
{{Family tree | K01 | | K02 | | | | | | | |K01=(Initial urine osmolality: 30 mOsm/kg and >50% increase after desmopressin):<br>'''Complete Central DI'''| K02=(Urine osmolality <300 mOsm/kg or <50% increase):<br>'''Complete Nephrogenic DI'''}}
{{Family tree/end}}
{{familytree/start |summary=polyuria diagnosis Algorithm.}}
{{familytree | | | | | | | | A01 |A01='''Polyuria'''<br> ❑ 24-hour urine volume >'''3'''L <br> ❑ 24-hour urine volume >50 ml/kg}}
{{familytree | | | | |,|-|-|-|^|-|-|-|-|.| | | }}
{{familytree | | | B01 | | | | | | | | B02 | | |B01='''Urine Osmolality >300'''mosmol|B02='''Urine Osmolality <300<ref>Robertson GL: Diabetes insipidus. Endocrinol Metab Clin North Am 24:549–572, 1995.</ref>'''mosmol}}
{{familytree | | | |!| | | | | | | | | |!| }}
{{familytree | | | C01 | | | | | | | | |!| |C01='''Solute diuresis'''<br> ❑ [[Glucose]] <br> ❑ [[Mannitol]] <br> ❑ [[Contrast media]] <br> ❑ [[High protein intake]] <br> ❑ [[Diuretics]] <br> ❑ [[Medullary cystic disease]] <br> ❑ [[Resolving ATN]] <br> ❑ [[Resolving obstruction]] }}
{{familytree | | | | | | | | | | | | | |!| }}
{{familytree | | | | | | | | | | | | | D03 |D03='''Water diuresis'''<br> ❑ [[Primary polydipsia]] <br> ❑ [[Diabetes inspidous]]}}
{{familytree | | | | | | | | | | | | | |!| | }}
{{familytree | | | | | | | | | | | | | E02 | | |E02=Water restriction test '''OR''' administration of hypertonic saline 0.05 mL/kg/min for 2 h|}}
{{familytree | | | | | | | | | | | | | |!| | | }}
{{familytree | | | | | | | | | | | | | F01 | | | |F01='''Water restriction test'''
<br> ❑ Overnight fluid restriction should be '''avoided''' <br> ❑ Recommend the patient to stop drinking 2-3 hours before coming to clinic <br> ❑ Meaure urine volume every hour <br> ❑ Measure urine osmolality every hour <br> ❑ Measure plasma sodium concentration every 2 hours <br> ❑ Measure plasma osmolality every 2 hours |F02=F02}}
{{familytree | | | | | | | | | | | | | |!| }}
{{familytree | | | | | | | | | | | | | G01 |G01='''Test endpoints in adults:''' <br> ❑ Urine osmolality reaches normal value (above 600 mosmol/kg)[means that ADH release and effect are intact] <br> ❑ The urine osmolality is stable for 2 or 3 successive hourly measurements despite a rising plasma osmolality <br> ❑ Plasma osmolality >295-300 mosmol/kg <br> ❑  Plasma sodium is 145 or higher |}}
{{familytree | | | | | | | | | | | | | |!| | | }}
{{familytree | | | | | | | | | | | | | H01 |H01=In the last 3 settings '''[[desmopressin]] 10mcg intranasal''', or 4mcg SC/IV is administered <br> ❑ Measure urine volume and urine osmolality every 30 minutes over the next two hours|}}
{{familytree | | | | | | | | | |,|-|-|-|+|-|-|-|.|}}
{{familytree | | | | | | | | |I01 | |I02 | | |I03|I01=>100% rise in urine osmolality|I02=15-50% rise in urine osmolality after administration of exogenous [[desmopressin]]|I03=<15% rise in urine osmolality}}
{{familytree | | | | | | | | | |!| | | |!| | | |!|}}
{{familytree | | | | | | | | |J01 | |J02 | | |J03|J01='''Complete central diabetes inspidous'''<ref>Zerbe RL, Robertson GL: A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria. The New England journal of medicine 1981, 305(26):1539-1546.</ref>|J02='''Partial central DI''' or '''partial nephrogenic DI'''<ref>Miller M, Dalakos T, Moses AM, Fellerman H, Streeten DH: Recognition of partial defects in antidiuretic hormone secretion. Annals of internal medicine 1970, 73(5):721-729.</ref>|J03='''complete nephrogenic DI''' or [['''primary polydipsia''']]|}}
{{familytree | | | | | | | | | | | | | |!| }}
{{familytree | | | | | | | | | | | | | K01 |K01=Check plasma and urine [[ADH]]<ref>Diederich S, Eckmanns T, Exner P, Al-Saadi N, Bahr V, Oelkers W: Differential diagnosis of polyuric/polydipsic syndromes with the aid of urinary vasopressin measurement in adults. Clinical endocrinology 2001, 54(5):665-671.</ref>and [[copeptin]] prior to administration of exogenous ADH <br> ❑ Increase in plasma/urine [[ADH]] in response to rising plasma osmolality '''excludes''' [[central DI]] <br> ❑ Appropriate elevation in [[urine osmolality]] as [[ADH]] secretion is increased '''excludes''' nephrogenic DI  <br> ❑ '''[[Copeptin]] > 21.4''' picomol/L differentiates Nephrogenic DI from other etiologies with 100% sensivity and specifity<ref> Timper K, Fenske W, Kuhn F, Frech N, Arici B, Rutishauser J, Kopp P, Allolio B, Stettler C, Muller B et al: Diagnostic Accuracy of Copeptin in the Differential Diagnosis of the Polyuria-polydipsia Syndrome: A Prospective Multicenter Study. The Journal of clinical endocrinology and metabolism 2015, 100(6):2268-2274.</ref>|}}
{{Family tree/end}}
{{Family tree/end}}



Revision as of 13:47, 25 September 2020

Overview

Causes

Life Threatening Causes

  • Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
  • Polyuria does not have life threatening causes.

Common causes [3] [2]

Management

  • Diagnostic Approach


 
 
 
 
 
 
 
 
 
 
 
 
Suspected hypotonic polyuria[4]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Confirm presence of polyuria:
(>50ml/kg/24hrs or >3-4L/day)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Polyuria confirmed):
Measure urine osmolality
 
 
 
(No polyuria/ or >800 mOsm/kg):
Diabetes insipidus(DI)/Primary polydipsia ruled out
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(<800 mOsm/kg):
Hypotonic polyuria confirmed:
Measure serum Sodium and plasma osmolality
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Low normal or low serum Sodium (<150 mmol/L), plasma osmolality (<280 mOsm/kg):
Primary polydipsia
 
 
 
 
Normal serum Sodium/plasma osmolality:
Indeterminate diagnosis
 
 
 
High serum Sodium (>146 mmol/L), plasma osmolality (>300 mOsm/kg):
Central or Nephrogenic DI
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Water deprivation test
 
 
 
 
 
Baseline plasma copeptin
 
 
 
Hypertonic saline infusion test
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Urine Osm >800 mOsm/kg
 
Urine Osm <300 mOsm/kg
 
Urine Osm 300-800 mOsm/kg
 
 
 
 
 
 
Plasma coprptin >4.9pmol/L
 
Plasma coprptin <4.9pmol/L
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mild primary polyuria
 
Desmopressin administration
 
 
 
 
>21pmol/L
 
<2.6pmol/L
 
>2.6pmol/L
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Urine Osmolality: 300-800 mOsm/Kg and <50% increase):
Therapeutic trial with desmopressin
 
Nephrogenic DI(partial or complete)
 
Complete Central DI
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primary polydipsia
 
Partial Nephrogenic DI
 
Partial Central DI
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Initial urine osmolality: 30 mOsm/kg and >50% increase after desmopressin):
Complete Central DI
 
(Urine osmolality <300 mOsm/kg or <50% increase):
Complete Nephrogenic DI
 
 
 
 
 
 
 


 
 
 
 
 
 
 
Polyuria
❑ 24-hour urine volume >3L
❑ 24-hour urine volume >50 ml/kg
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Urine Osmolality >300mosmol
 
 
 
 
 
 
 
Urine Osmolality <300[5]mosmol
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Solute diuresis
Glucose
Mannitol
Contrast media
High protein intake
Diuretics
Medullary cystic disease
Resolving ATN
Resolving obstruction
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Water diuresis
Primary polydipsia
Diabetes inspidous
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Water restriction test OR administration of hypertonic saline 0.05 mL/kg/min for 2 h
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Water restriction test
❑ Overnight fluid restriction should be avoided
❑ Recommend the patient to stop drinking 2-3 hours before coming to clinic
❑ Meaure urine volume every hour
❑ Measure urine osmolality every hour
❑ Measure plasma sodium concentration every 2 hours
❑ Measure plasma osmolality every 2 hours
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Test endpoints in adults:
❑ Urine osmolality reaches normal value (above 600 mosmol/kg)[means that ADH release and effect are intact]
❑ The urine osmolality is stable for 2 or 3 successive hourly measurements despite a rising plasma osmolality
❑ Plasma osmolality >295-300 mosmol/kg
❑ Plasma sodium is 145 or higher
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In the last 3 settings desmopressin 10mcg intranasal, or 4mcg SC/IV is administered
❑ Measure urine volume and urine osmolality every 30 minutes over the next two hours
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
>100% rise in urine osmolality
 
15-50% rise in urine osmolality after administration of exogenous desmopressin
 
 
<15% rise in urine osmolality
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Complete central diabetes inspidous[6]
 
Partial central DI or partial nephrogenic DI[7]
 
 
complete nephrogenic DI or '''primary polydipsia'''
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Check plasma and urine ADH[8]and copeptin prior to administration of exogenous ADH
❑ Increase in plasma/urine ADH in response to rising plasma osmolality excludes central DI
❑ Appropriate elevation in urine osmolality as ADH secretion is increased excludes nephrogenic DI
Copeptin > 21.4 picomol/L differentiates Nephrogenic DI from other etiologies with 100% sensivity and specifity[9]

Do's

Don'ts

References

  1. Moore K, Thompson C, Trainer P (2003). "Disorders of water balance". Clin Med (Lond). 3 (1): 28–33. doi:10.7861/clinmedicine.3-1-28. PMC 4953350. PMID 12617410.
  2. 2.0 2.1 Weiss JP, Everaert K (2019). "Management of Nocturia and Nocturnal Polyuria". Urology. 133S: 24–33. doi:10.1016/j.urology.2019.09.022. PMID 31586470.
  3. Wieliczko M, Matuszkiewicz-Rowińska J (2013). "[Polyuria]". Wiad Lek. 66 (4): 324–8. PMID 24490488.
  4. Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K; et al. (2000). "Endotext". PMID 30779536.
  5. Robertson GL: Diabetes insipidus. Endocrinol Metab Clin North Am 24:549–572, 1995.
  6. Zerbe RL, Robertson GL: A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria. The New England journal of medicine 1981, 305(26):1539-1546.
  7. Miller M, Dalakos T, Moses AM, Fellerman H, Streeten DH: Recognition of partial defects in antidiuretic hormone secretion. Annals of internal medicine 1970, 73(5):721-729.
  8. Diederich S, Eckmanns T, Exner P, Al-Saadi N, Bahr V, Oelkers W: Differential diagnosis of polyuric/polydipsic syndromes with the aid of urinary vasopressin measurement in adults. Clinical endocrinology 2001, 54(5):665-671.
  9. Timper K, Fenske W, Kuhn F, Frech N, Arici B, Rutishauser J, Kopp P, Allolio B, Stettler C, Muller B et al: Diagnostic Accuracy of Copeptin in the Differential Diagnosis of the Polyuria-polydipsia Syndrome: A Prospective Multicenter Study. The Journal of clinical endocrinology and metabolism 2015, 100(6):2268-2274.